Your institution may have access to this item. Find your institution then sign in to continue.
Title
Heart drug double trouble for AZ.
Abstract
The article reports on the decisions of the U.S. District Court that the two key patents of AstraZeneca PLC angina drug metoprolol succinate are invalid and enforceable. This ruling of the court comes after the pharmaceutical industry has sued several drugmakers for filing Abbreviated New Drug Application for generic versions of the drug. The court considers that the drug are invalid because of double patenting and enforceable due to inequitable conduct.